Search research articles
Contact Us
Filters
Showing results (131-140 of 225) with videos related to
Page
of 23
Sort By:
Disease Markers
|
October 2, 2018
Testing a Combination of Markers of Systemic Redox Status as a Possible Tool for the Diagnosis of Late Onset Alzheimer's Disease
Giovanni Zuliani, Angelina Passaro, Cristina Bosi, et al.
Genes, Chromosomes & Cancer
|
February 16, 2007
A combined analytical approach reveals novel EXT1/2 gene mutations in a large cohort of Italian multiple osteochondromas patients
Emanuela Signori, Emanuela Massi, Maria Giovanna Matera, et al.
Immunotherapy
|
August 4, 2016
Tau-based therapeutics for Alzheimer's disease: active and passive immunotherapy
Francesco Panza, Vincenzo Solfrizzi, Davide Seripa, et al.
The Journal of Orthopaedic and Sports Physical Therapy
|
August 2, 2016
Is Extracorporeal Shockwave Therapy Combined With Isokinetic Exercise More Effective Than Extracorporeal Shockwave Therapy Alone for Subacromial Impingement Syndrome? A Randomized Clinical Trial
Andrea Santamato, Francesco Panza, Angela Notarnicola, et al.
Journal of Alzheimer'S Disease : JAD
|
June 5, 2009
Alcohol drinking, cognitive functions in older age, predementia, and dementia syndromes
Francesco Panza, Cristiano Capurso, Alessia D'Introno, et al.
Dementia and Geriatric Cognitive Disorders
|
February 28, 2008
Association analysis of GRIN2B, encoding N-methyl-D-aspartate receptor 2B subunit, and Alzheimer's disease
Davide Seripa, Maria Giovanna Matera, Marilisa Franceschi, et al.
Expert Opinion on Emerging Drugs
|
August 11, 2020
Anti-amyloid-β protein agents for the treatment of Alzheimer's disease: an update on emerging drugs
Madia Lozupone, Vincenzo Solfrizzi, Francesca D'Urso, et al.
Journal of the Neurological Sciences
|
August 15, 2018
Plasma β-amyloid<sub>1-42</sub> reference values in cognitively normal subjects
Chiara Zecca, Rosanna Tortelli, Francesco Panza, et al.
Medicine
|
September 15, 2018
CYP2D6 genotypes in revolving door patients with bipolar disorders: A case series
Davide Seripa, Madia Lozupone, Giuseppe Miscio, et al.
Biomed Research International
|
July 19, 2016
Tau-Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer's Disease
Francesco Panza, Vincenzo Solfrizzi, Davide Seripa, et al.
Page
of 23
Search research articles
Search
Showing results (131-140 of 225) with videos related to
Sort By:
Page
of 23
Disease Markers
|
October 2, 2018
Testing a Combination of Markers of Systemic Redox Status as a Possible Tool for the Diagnosis of Late Onset Alzheimer's Disease
Giovanni Zuliani, Angelina Passaro, Cristina Bosi, et al.
Genes, Chromosomes & Cancer
|
February 16, 2007
A combined analytical approach reveals novel EXT1/2 gene mutations in a large cohort of Italian multiple osteochondromas patients
Emanuela Signori, Emanuela Massi, Maria Giovanna Matera, et al.
Immunotherapy
|
August 4, 2016
Tau-based therapeutics for Alzheimer's disease: active and passive immunotherapy
Francesco Panza, Vincenzo Solfrizzi, Davide Seripa, et al.
The Journal of Orthopaedic and Sports Physical Therapy
|
August 2, 2016
Is Extracorporeal Shockwave Therapy Combined With Isokinetic Exercise More Effective Than Extracorporeal Shockwave Therapy Alone for Subacromial Impingement Syndrome? A Randomized Clinical Trial
Andrea Santamato, Francesco Panza, Angela Notarnicola, et al.
Journal of Alzheimer'S Disease : JAD
|
June 5, 2009
Alcohol drinking, cognitive functions in older age, predementia, and dementia syndromes
Francesco Panza, Cristiano Capurso, Alessia D'Introno, et al.
Dementia and Geriatric Cognitive Disorders
|
February 28, 2008
Association analysis of GRIN2B, encoding N-methyl-D-aspartate receptor 2B subunit, and Alzheimer's disease
Davide Seripa, Maria Giovanna Matera, Marilisa Franceschi, et al.
Expert Opinion on Emerging Drugs
|
August 11, 2020
Anti-amyloid-β protein agents for the treatment of Alzheimer's disease: an update on emerging drugs
Madia Lozupone, Vincenzo Solfrizzi, Francesca D'Urso, et al.
Journal of the Neurological Sciences
|
August 15, 2018
Plasma β-amyloid<sub>1-42</sub> reference values in cognitively normal subjects
Chiara Zecca, Rosanna Tortelli, Francesco Panza, et al.
Medicine
|
September 15, 2018
CYP2D6 genotypes in revolving door patients with bipolar disorders: A case series
Davide Seripa, Madia Lozupone, Giuseppe Miscio, et al.
Biomed Research International
|
July 19, 2016
Tau-Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer's Disease
Francesco Panza, Vincenzo Solfrizzi, Davide Seripa, et al.
Page
of 23